Wed May 18, 2022 – 2:32 pm EDT
(LifeSiteNews) – The U.S. Food and Drug Administration (FDA) sanctioned Pfizer’s mRNA COVID-19 booster shots for children five years of age and older on Tuesday under its emergency use authorization (EUA) protocol.
Children aged between five and 11 in the U.S. have been allowed to take a two-shot regimen of the experimental drug since late October, 2021, at which time the regulatory body endorsed a one-third dose-per-shot regimen for the age group.
The FDA’s Tuesday approval now means that children aged five through 11 can receive a single booster dose of Pfizer’s COVID jab, provided they took the two-shot “primary series” at least five months prior.
Today, we amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to children 5-11 at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine. https://t.co/2PNNFPqAwe pic.twitter.com/khpG0DLou3
— U.S. FDA (@US_FDA) May 17, 2022
In an accompanying press release, FDA Commissioner Dr. Robert Califf said that the agency “is authorizing the use of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for children 5 through 11 years
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
